Effects of the early diagnosis of amyotrophic lateral sclerosis on the patient: Disadvantages

Amyotrophic Lateral Sclerosis

Volumn 1, Issue SUPPL. 1, 2000, Pages

  Smith, Richard Alan ^a  

^a The Center for Neurologic Study   (United States)

Author keywords

ALS; diagnosis; ethics

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; COST OF ILLNESS; DIAGNOSTIC ERROR; ECONOMICS; HUMAN; MEDICAL ETHICS; MOTOR NEURON DISEASE; PROGNOSIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE;

COST OF ILLNESS; COST-BENEFIT ANALYSIS; DIAGNOSTIC ERRORS; ETHICS, MEDICAL; HUMANS; MOTOR NEURON DISEASE; PROGNOSIS; QUALITY OF LIFE;

EID: 0347309090     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/14660820050515610     Document Type: Article

References (7)

1. Chaudhuri KR, Crump S, al-Sarraj S et al. The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: a clinicopathological study. J Neurol Sci 1995; 129: 11-12.
2. Miller RG, Rosenberg JA, Gelinas DF et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: Academy of Neurology: ALS Practice Parameters Task Force. Neurology 1999; 52: 1311-1323.
3. Pardes H, Manton KG, Lander ES et al. Effects of medical research on health care and economy. Science 1999; 283: 36-37.
4. Rosenbaum S, Frankford DM, Moore B et al. Who should determine when health care is medically necessary? N Engl J Med 1999; 340: 229-232.
5. Brown ML, Kassler LG. The use of gene tests to detect hereditary predisposition to cancer: economic considerations. J Natl Cancer Inst 1995; 87: 1131-1136.
6. Swash M. Early diagnosis of ALS/MND. J Neurol Sci 1998; 160 (suppl 1): S33-S36.
7. Garber JE, Patenaude AF. Ethical, social and counseling issues in hereditary cancer susceptibility. Cancer Surv 1995; 25: 381-397.